Invictus RG’s Amedisys AMED Stock Holding History

Invictus RG’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,302	Closed	-$288K	–	15
2018 Q3	$288K	Sell	2,302 -1,332	-37%	-$147K	0.22%	140
2018 Q2	$311K	Buy	+3,634	New	+$267K	0.26%	107
2017 Q2	–	Sell	-8,317	Closed	-$425K	–	623
2017 Q1	$425K	Buy	+8,317	New	+$397K	0.29%	109
2016 Q4	–	Sell	-5,355	Closed	-$254K	–	622
2016 Q3	$254K	Buy	5,355 +2,542	+90%	+$127K	0.2%	187
2016 Q2	$142K	Buy	2,813 +1,700	+153%	+$85.8K	0.15%	234
2016 Q1	$54K	Sell	1,113 -3,496	-76%	-$135K	0.07%	335
2015 Q4	$181K	Buy	+4,609	New	+$184K	0.17%	223

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invictus RG's AMED Position: Q4 2018 in Review

Invictus RG sold out of Amedisys (AMED) in Q4 2018, closing a stake of 2,302 shares — an estimated $288K sold.

Invictus RG first reported a position in AMED in Q4 2015 and held it in 7 quarters. The position peaked at $425K in Q1 2017. 297 funds tracked by Wall St. Rank hold AMED as of Q4 2018.

Invictus RG reported no remaining Amedisys position as of Q4 2018 after selling out during the quarter.
Invictus RG sold 2,302 Amedisys shares in Q4 2018, an estimated $288K.
Invictus RG first reported a position in Amedisys in Q4 2015 and held it in 7 quarters.
Invictus RG's Amedisys position peaked at $425K in Q1 2017.
297 funds tracked by Wall St. Rank held Amedisys as of Q4 2018.

Based on Invictus RG's 13F filing for Q4 2018, filed 13 Feb 2019.